A few months ago, Scott Gavura wrote about how the veterinary deworming drug ivermectin has become the new hydroxychloroquine in that it is being promoted as a highly effective treatment against COVID-19—and by many of the same people who previously
Health leaders say planning for an autumn rollout must start now as it will involve bigger challenges.
Every adult in India is now eligible for a free vaccine paid for by the federal government
Thousands of Japanese companies began distributing COVID-19 vaccines to workers and their families Monday in an employer-led drive that aims to rev up the nation’s slow vaccine rollout
The government has already promised a Covid booster rollout but it is yet to set out how it will work.
A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries.
A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers.
Ex-pupils caught up in the infected blood scandal decades ago will give evidence at an inquiry.
Some New England hospitals are delaying or rescheduling surgeries because of a shortage of blood donations during the pandemic
Portuguese authorities have confirmed suspicions that the new delta variant of the coronavirus is driving a spike in new cases in the Lisbon region
Uveitis is an inflammation of the eye and is a common extra-articular manifestation associated with juvenile idiopathic arthritis (JIA). It can cause vision-threatening complications, and if left uncontrolled may even lead to blindness.
Pioneering technology developed by UCL and Africa Health Research Institute researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.